Patrick J. McGrath, M.D.
Professor of Clinical Psychiatry
Co-Director Depression Evaluation Service, Department of Psychiatry,
New York State Psychiatric Institute
Dr. McGrath is a specialist in the clinical psychopharmacology of mood and anxiety disorders. He is currently Co-Director of the Depression Evaluation Service at the New York State Psychiatric Institute which conducts research into all aspects of the diagnosis and treatment of mood disorders. Special current research interests of Dr. McGrath's include pharmacogenetics, which is the effort to determine genetic determinants of response to antidepressant medications; brain imaging using positron emission tomography (PET) and functional magnetic ressonance imagaing (fMRI) to determine the biology of response to antidepressants; prediction of loss of response to antidepressant medication; and the effects of alcohol abuse and dependence on the response to antidepressants.
Undergraduate: Seton Hall University, B.S., Magna Cum Laude, 1970-1974
Medical School: Columbia University College of Physicians & Surgeons, M.D., 1974
Internship: Presbyterian Hospital, Surgery, 1974 - 1975
Residency: NYS Psychiatric Institute, Psychiatry, 1975 - 1978
Fellowship: NYS Psychiatric Institute, Clinical Psychopharmacology Research, 1975-1976
Board Certifications: American Board of Psychiatry and Neurology
• Clinical Psychopharmacology of Mood Disorders
NYS Psychiatric Institute
Room 3716 Unit/Box:51
1051 Riverside Drive
New York, NY 10032
Dr. McGrath's research has focussed on the clinical psychopharmacologic treatment of mood disorders, including anxiety and co-morbid substance use disorders such as alcoholism.
1. McGrath PJ, Stewart JW, Quitkin FM, Chen Y, Alpert JE, Nierenberg AA, Fava M, Cheng J, Petkova E: A prospective study of predictors of relapse during fluoxetine treatment of major depression. American Journal of Psychiatry 2006;In Press
2. McGrath PJ, Stewart JW, Petkova E, Quitkin FM, Amsterdam JD, Fawcett J, Reimherr FW, Rosenbaum JF, Beasley CM: Predictors of relapse during fluoxetine continuation or maintenance treatment of major depression. Journal of Clinical Psychiatry 2000;61: 518-524
3. McGrath PJ, Nunes EV, Stewart JW, Goldman D, Agosti V, Ocepek-Welikson K, Quitkin FM: Imipramine treatment of alcoholics with primary depression. Archives of General Psychiatry 1996;53: 232-240